FULC: Fulcrum Therapeutics, Inc. Stock

by  •  • Comments Off on FULC: Fulcrum Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 455.59
Enterprise Value ($M) 430.02
Book Value ($M) 235.19
Book Value / Share 3.78
Price / Book 1.94
NCAV ($M) 219.70
NCAV / Share 3.53
Price / NCAV 2.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.40
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.33

Liquidity (mrq)
Quick Ratio 17.71
Current Ratio 17.71

Balance Sheet (mrq) ($M)
Current Assets 242.20
Assets 257.69
Liabilities 22.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.81
Operating Income -110.66
Net Income -97.33
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -90.97
Cash from Investing -36.69
Cash from Financing 118.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Rtw Investments, Lp 8.80 9.55
02-14 13G/A Third Rock Ventures III, L.P. 3.80 0.00
02-14 13G/A Ra Capital Management, L.p. 18.80 19.85
02-13 13G/A Suvretta Capital Management, Llc 8.90 29.10
02-09 13G/A Fmr Llc 9.20 8.62
02-07 13G/A Adage Capital Partners Gp, L.l.c. 2.44 -56.59
07-07 13G/A BlackRock Inc. 2.50 -53.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-06-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2023-06-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2023-06-23 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 41,457 164,495 25.20
2024-05-01 51,892 133,499 38.87
2024-04-30 50,468 131,534 38.37
2024-04-29 64,955 99,723 65.14

(click for more detail)

Similar Companies
FBLG – FibroBiologics, Inc. FHTX – Foghorn Therapeutics Inc.
FOLD – Amicus Therapeutics, Inc. GANX – Gain Therapeutics, Inc.
GHRS – GH Research PLC


Financial data and stock pages provided by
Fintel.io